Low adiponectin, high levels of apoptosis and increased peripheral blood neutrophil activity in healthy obese subjects

Obesity Facts

Volumn 5, Issue 3, 2012, Pages 305-318

  Trellakis, Sokratis ^a   Rydleuskaya, Alena ^a   Fischer, Cornelia ^a   Canbay, Ali ^a   Tagay, Sefik ^a   Scherag, André ^a   Bruderek, Kirsten ^a   Schuler, Patrick J ^a   Brandau, Sven ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Adipocytokines; Apoptosis; Inflammation; Neutrophils; Obesity

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CELL PROTEIN; CYTOKINE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROTEIN M30; PROTEIN M65; RANTES; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; BLOOD CELL COUNT; CELL ACTIVITY; CELL FUNCTION; CELL STIMULATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE; MALE; NEUTROPHIL; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPONECTIN; ADULT; APOPTOSIS; C-REACTIVE PROTEIN; CHEMOKINES; FEMALE; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MALE; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; OBESITY; OVERWEIGHT; REFERENCE VALUES; YOUNG ADULT;

EID: 84862507679     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000339452     Document Type: Article

References (49)

1. Theilgaard-Monch K, Porse BT, Borregaard N: Systems biology of neutrophil differentiation and immune response. Curr Opin Immunol 2006; 18: 54-60.
2. Elgazar-Carmon V, Rudich A, Hadad N, Levy R: Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res 2008; 49: 1894-1903.
3. Schymeinsky J, Mocsai A, Walzog B: Neutrophil activation via beta2 integrins (CD11/CD18): Molecular mechanisms and clinical implications. Thromb Haemost 2007; 98: 262-273.
4. Tilg H, Moschen AR: Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772-783.
5. Rasouli N, Kern PA: Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 2008; 93:S64-S73.
6. Ouchi N, Parker JL, Lugus JJ, Walsh K: Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85-97.
7. Ferrante AW Jr: Obesity-induced inflammation: A metabolic dialogue in the language of inflammation. J Intern Med 2007; 262: 408-414.
8. Brookheart RT, Michel CI, Schaffer JE: As a matter of fat. Cell Metab 2009; 10: 9-12.
9. Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O: Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 2010; 122: 1837-1845.
10. Shah TJ, Leik CE, Walsh SW: Neutrophil infiltration and systemic vascular inflammation in obese women. Reprod Sci 2010; 17: 116-124.
11. Dixon JB, O'Brien PE: Obesity and the white blood cell count: Changes with sustained weight loss. Obes Surg 2006; 16: 251-257.
12. Nijhuis J, Rensen SS, Slaats Y, van Dielen FM, Buurman WA, Greve JW: Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring) 2009; 17: 2014-2018.
13. Lowe B, Grafe K, Zipfel S, Spitzer RL, Herrmann-Lingen C, Witte S, Herzog W: Detecting panic disorder in medical and psychosomatic outpatients: Comparative validation of the Hospital Anxiety and Depression Scale, the Patient Health Questionnaire, a screening question, and physicians' diagnosis. J Psychosom Res 2003; 55: 515-519.
14. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP: Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 2005; 54: 333-339.
15. Suttmann H, Riemensberger J, Bentien G, Schmaltz D, Stockle M, Jocham D, Bohle A, Brandau S: Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses. Cancer Res 2006; 66: 8250-8257.
16. Greystoke A, Cummings J, Ward T, Simpson K, Renehan A, Butt F, Moore D, Gietema J, Blackhall F, Ranson M, Hughes A, Dive C: Optimisation of circulating biomarkers of cell death for routine clinical use. Ann Oncol 2008; 19: 990-995.
17. Tan S, Bechmann LP, Benson S, Dietz T, Eichner S, Hahn S, Janssen OE, Lahner H, Gerken G, Mann K, Canbay A: Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome. J Clin Endocrinol Metab 2010; 95: 343-348.
18. Baggiolini M, Loetscher P, Moser B: Interleukin-8 and the chemokine family. Int J Immunopharmacol 1995; 17: 103-108.
19. Fain JN: Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: A review. Mediators Inflamm 2010; 2010: 513948.
20. Labruna G, Pasanisi F, Nardelli C, Caso R, Vitale DF, Contaldo F, Sacchetti L: High Leptin/adiponectin ratio and serum triglycerides are associated with an 'at-risk' phenotype in young severely obese patients. Obesity (Silver Spring) 2010.
21. Murphy PM: Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin Hematol 1997; 34: 311-318.
22. Ferrandi C, Ardissone V, Ferro P, Ruckle T, Zaratin P, Ammannati E, Hauben E, Rommel C, Cirillo R: Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment. J Pharmacol Exp Ther 2007; 322: 923-930.
23. Fernandez-Riejos P, Najib S, Santos-Alvarez J, Martin-Romero C, Perez-Perez A, Gonzalez-Yanes C, Sanchez- Margalet V: Role of leptin in the activation of immune cells. Mediators Inflamm 2010; 2010: 568343.
24. Baetta R, Corsini A: Role of polymorphonuclear neutrophils in atherosclerosis: Current state and future perspectives.Atherosclerosis 2010; 210: 1-13.
25. Kyrou I, Chrousos GP, Tsigos C: Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci 2006; 1083: 77-110.
26. Hillman JB, Dorn LD, Loucks TL, Berga SL: Obesity and the hypothalamic-pituitary-adrenal axis in adolescent girls. Metabolism 2012; 61: 341-348.
27. Bjorntorp P, Rosmond R: Obesity and cortisol. Nutrition 2000; 16: 924-936.
28. Strickland I, Kisich K, Hauk PJ, Vottero A, Chrousos GP, Klemm DJ, Leung DY: High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med 2001; 193: 585-593.
29. Plumb J, Gaffey K, Kane B, Malia-Milanes B, Shah R, Bentley A, Ray D, Singh D: Reduced glucocorticoid receptor expression and function in airway neutrophils. Int Immunopharmacol 2012; 12: 26-33.
30. Ignacchiti MD, Sesti-Costa R, Marchi LF, Chedraoui-Silva S, Mantovani B: Effect of academic psychological stress in post-graduate students: The modulatory role of cortisol on superoxide release by neutrophils. Stress 2011; 14: 290-300.
31. Moreno-Navarrete JM, Ortega FJ, Bassols J, Ricart W, Fernandez-Real JM: Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes. J Clin Endocrinol Metab 2009; 94: 4036-4044.
32. Legrand D, Mazurier J: A critical review of the roles of host lactoferrin in immunity. Biometals 2010; 23: 365-376.
33. Azekoshi Y, Yasu T, Watanabe S, Tagawa T, Abe S, Yamakawa K, Uehara Y, Momomura S, Urata H, Ueda S: Free fatty acid causes leukocyte activation and resultant endothelial dysfunction through enhanced angiotensin II production in mononuclear and polymorphonuclear cells. Hypertension 2010; 56: 136-142.
34. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS: TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025.
35. Schaeffler A, Gross P, Buettner R, Bollheimer C, Buechler C, Neumeier M, Kopp A, Schoelmerich J, Falk W: Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 2009; 126: 233-245.
36. Fukata M, Vamadevan AS, Abreu MT: Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Semin Immunol 2009; 21: 242-253.
37. Xiang M, Fan J, Fan J: Association of Toll-like receptor signaling and reactive oxygen species: A potential therapeutic target for posttrauma acute lung injury. Mediators Inflamm 2010; 2010.
38. Lee JY, Ye J, Gao Z, Youn HS, Lee WH, Zhao L, Sizemore N, Hwang DH: Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 2003; 278: 37041-37051.
39. Chung S, Lapoint K, Martinez K, Kennedy A, Boysen SM, McIntosh MK: Preadipocytes mediate lipopolysaccharide- induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 2006; 147: 5340-5351.
40. Alhusaini S, McGee K, Schisano B, Harte A, McTernan P, Kumar S, Tripathi G: Lipopolysaccharide, high glucose and saturated fatty acids induce endoplasmic reticulum stress in cultured primary human adipocytes: Salicylate alleviates this stress. Biochem Biophys Res Commun 2010; 397: 472-478.
41. Hummasti S, Hotamisligil GS: Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ Res 2010; 107: 579-591.
42. Lajunen T, Vikatmaa P, Bloigu A, Ikonen T, Lepantalo M, Pussinen PJ, Saikku P, Leinonen M: Chlamydial LPS and high-sensitivity CRP levels in serum are associated with an elevated body mass index in patients with cardiovascular disease. Innate Immun 2008; 14: 375-382.
43. Muccioli GG, Naslain D, Backhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD: The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 2010; 6: 392.
44. Weigert J, Neumeier M, Wanninger J, Wurm S, Kopp A, Schober F, Filarsky M, Schaffler A, Zeitoun M, Aslanidis C, Buechler C: Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes. FEBS Lett 2008; 582: 1777-1782.
45. Anderson EK, Gutierrez DA, Hasty AH: Adipose tissue recruitment of leukocytes. Curr Opin Lipidol 2010; 21: 172-177.
46. Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, Gokce N, Pedersen AA, Kalthoff C, Tullin S, Sams A, Summer R, Walsh K: Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem 2010; 285: 6153-6160.
47. Ouchi N, Parker JL, Lugus JJ, Walsh K: Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85-97.
48. Magalang UJ, Rajappan R, Hunter MG, Kutala VK, Kuppusamy P, Wewers MD, Marsh CB, Parinandi NL: Adiponectin inhibits superoxide generation by human neutrophils. Antioxid Redox Signal 2006; 8: 2179-2186.
49. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM: Polarization of tumor-associated neutrophil phenotype by TGF-beta: 'N1' versus 'N2' TAN. Cancer Cell 2009; 16: 183-194.